This study provides both in vivo and in vitro evidence that FGF21 potently protects the dopaminergic neurons through the promotion of microglial M2 polarization via the SIRT1/NF-κB pathway in a PD model. This evidence concerns the gene NFKB1 and Parkinson disease.